Sort
30,917 grants matching “tumor microenvironment”
Engineered Invasive Human Breast Tumors with Integrated Capillaries and Lymphatics
$571,159Joe Y Tien · Boston University (Charles River Campus) · U01 · FY2017 · CA
Phase II Clinical Development of Galectin-3 Inhibition and Anti-PD-1: Immune Monitoring and Tumor Response
$571,136Brendan D Curti · Providence Portland Medical Center · R01 · FY2024 · CA
Overcoming hypoxic resistance to anti-cancer therapy
$571,062Nicholas C Denko · Ohio State University · R01 · FY2022 · CA
Overcoming hypoxic resistance to anti-cancer therapy
$571,062Nicholas C Denko · Ohio State University · R01 · FY2023 · CA
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
$571,003Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2020 · CA
Improving anti-tumor T cell immunity by targeting LDH-A functions beyond the Warburg effect
$571,003Vassiliki A Boussiotis · Beth Israel Deaconess Medical Center · R01 · FY2021 · CA
The CANcer Cachexia Action Network (CANCAN): a Multidisciplinary Virtual Institute with the Mission to Cure Cancer Cachexia
$570,945Marcus Dasilva Goncalves · New York University School Of Medicine · OT2 · FY2024 · CA
Small molecule probes of MYC stability and function intumorigenesis
$570,930Sarki A. Abdulkadir · Northwestern University At Chicago · R01 · FY2025 · CA
Tumor Suppressor Protein, p53
$570,904Ettore Appella · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
Dual action immunostimulatory nanoparticles for treatment of aggressive cancers
$570,868Efstathios Karathanasis · Case Western Reserve University · R01 · FY2024 · CA
(PQ1) Genomic characterization of mesenchymal stromal cells in Monoclonal Gammopathy of Undermined Significance (MGUS)
$570,843Irene M. Ghobrial · Dana-Farber Cancer Inst · R01 · FY2019 · CA
Development of Novel Spontaneous HPV Cervicovaginal Carcinoma Models for Cancer Immunotherapy
$570,782T.-C. Wu · Johns Hopkins University · R01 · FY2023 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2017 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2016 · CA
Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts
$570,759Charles M Rudin · Sloan-Kettering Inst Can Research · U01 · FY2015 · CA
PROJECT 1: From Neurofibroma to MPNST: Models, Biology and Translation to Clinic
$570,750David W. Clapp · Indiana University Indianapolis · U54 · FY2021 · CA
Transcriptional heterogeneity and regulatory mechanisms in tumor microenvironment
$570,593Sridhar Hannenhalli · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA
The role of Galectin-1 in shaping the immune suppressive landscape in head and neck cancer
$570,587Quynh-Thu X Le · Stanford University · R01 · FY2022 · DE
Improving Glioma Immunotherapy Efficacy by Regulating Tumor Inflammation
$570,541Behnam Badie · Beckman Research Institute/City Of Hope · R01 · FY2024 · NS
Translational Pathology Core
$570,525William Dean Wallace · University Of Southern California · P30 · FY2023 · CA
Single Cell Genome-Wide Myeloid Response Profiling in Immunotherapy
$570,518Allon Moshe Klein · Harvard Medical School · R01 · FY2018 · CA
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation
$570,517Edgar G. Engleman · Stanford University · R01 · FY2016 · CA
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation
$570,517Edgar G. Engleman · Stanford University · R01 · FY2017 · CA
Applicability of Mouse Breast Cancer Models to Tumor-Immune Network Investigation
$570,517Edgar G. Engleman · Stanford University · R01 · FY2015 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia
$570,317Iannis Aifantis · New York University School Of Medicine · R01 · FY2023 · CA